Relative to wild-type mice, ApoE−/− mice fed an HFD exhibit reduced hepatic ABCA1 expression, whereas BBR treatment enhances the expression of ABCA1 and alleviates atherosclerotic lesions and hepatic steatosis (Ma et al., 2021a). Here, ABCA1 is linked to Hepatic steatosis.